EuroVacc’s primary objectives
Promote HIV vaccine research
To promote HIV vaccine research by bridging the strength of academic research groups with industrial expertise
Facilitate and support phase I & II clinical trials in Europe
To facilitate and support phase I & II clinical trials in Europe to expedite translational research from discovery to clinical development;
Partner with other international initiative
To partner with other international initiatives and industry for down-stream development and phase IIb/III trials.